Contactins in the central nervous system: role in health and disease

by Madhurima Chatterjee, Detlev Schild, Charlotte E Teunissen
Published 2019-01-01

Critical Steps to be Taken into Consideration Before Quantification of β-Amyloid and Tau Isoforms in Blood can be Implemented in a Clinical Environment

by Hugo Marcel Vanderstichele, Charlotte E. Teunissen, Eugeen Vanmechelen
Published 2019-12-01

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

by Marta Del Campo Milan, Leah Zuroff, Connie R. Jimenez, Philip Scheltens, Charlotte E. Teunissen
Published 2015-03-01

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias

by Claudia Cicognola, Oskar Hansson, Philip Scheltens, Hlin Kvartsberg, Henrik Zetterberg, Charlotte E. Teunissen, Kaj Blennow
Published 2021-02-01

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β(1-42), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

by Charlotte E. Teunissen, Niek A. Verwey, Maartje I. Kester, Kees van Uffelen, Marinus A. Blankenstein
Published 2010-01-01

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

by Inger van Steenoven, Wiesje M. van der Flier, Philip Scheltens, Charlotte E. Teunissen, Afina W. Lemstra
Published 2019-10-01

Diurnal Cortisol Secretion Is Not Related to Multiple Sclerosis-Related Fatigue

by Arjan Malekzadeh, Ilona Bader, Julia van Dieteren, Annemieke C. Heijboer, Heleen Beckerman, Heleen Beckerman, Heleen Beckerman, Jos W. R. Twisk, Vincent de Groot, Vincent de Groot, Vincent de Groot, Charlotte E. Teunissen, Charlotte E. Teunissen
Published 2020-01-01

Effect of long‐term storage in biobanks on cerebrospinal fluid biomarker Aβ1‐42, T‐tau, and P‐tau values

by Eline A.J. Willemse, Kees W.J. vanUffelen, Wiesje M. van derFlier, Charlotte E. Teunissen
Published 2017-01-01

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF

by Walter A. Boiten, Inger van Steenoven, MeiFang Xiao, Paul F. Worley, Afina W. Lemstra, Charlotte E. Teunissen
Published 2021-12-01

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia

by Arianna Romani, Alessandro Trentini, Wiesje M. van der Flier, Tiziana Bellini, Giovanni Zuliani, Carlo Cervellati, Charlotte E. Teunissen
Published 2020-05-01

Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients

by Claire Bridel, Torsten Hoffmann, Antje Meyer, Sisi Durieux, Marleen A. Koel-Simmelink, Matthias Orth, Philip Scheltens, Inge Lues, Charlotte E. Teunissen
Published 2017-06-01

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

by Mara ten Kate, Frederik Barkhof, Pieter Jelle Visser, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Betty M. Tijms
Published 2017-09-01

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients

by Claudia Sestito, John J. P. Brevé, Joep Killestein, Charlotte E. Teunissen, Micha M. M. Wilhelmus, Benjamin Drukarch, Anne-Marie van Dam
Published 2018-11-01

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease

by Flora H. Duits, Gunnar Brinkmalm, Charlotte E. Teunissen, Ann Brinkmalm, Philip Scheltens, Wiesje M. Van der Flier, Henrik Zetterberg, Kaj Blennow
Published 2018-01-01

Lumbar puncture in patients with neurologic conditions

by Rosha Babapour Mofrad, Femke H. Bouwman, Rosalinde E.R. Slot, Tessa Timmers, Wiesje M. van derFlier, Philip Scheltens, Charlotte E. Teunissen
Published 2017-01-01

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

by Rosha Babapour Mofrad, Niki S.M. Schoonenboom, Betty M. Tijms, Philip Scheltens, Pieter Jelle Visser, Wiesje M. van derFlier, Charlotte E. Teunissen
Published 2019-12-01

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease

by Madhurima Chatterjee, Marta Del Campo, Tjado H. J. Morrema, Matthijs de Waal, Wiesje M. van der Flier, Jeroen J. M. Hoozemans, Charlotte E. Teunissen
Published 2018-06-01

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients

by Claire Bridel, Anand J. C. Eijlers, Wessel N. van Wieringen, Marleen Koel-Simmelink, Cyra E. Leurs, Menno M. Schoonheim, Joep Killestein, Charlotte E. Teunissen
Published 2018-10-01

Plasma proteome in multiple sclerosis disease progression

by Arjan Malekzadeh, Cyra Leurs, Wessel vanWieringen, Martijn D. Steenwijk, Menno M. Schoonheim, Michael Amann, Yvonne Naegelin, Jens Kuhle, Joep Killestein, Charlotte E. Teunissen
Published 2019-09-01

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach

by Karin D. van Dijk, Charlotte E. Teunissen, Benjamin Drukarch, Connie R. Jimenez, Henk J. Groenewegen, Henk W. Berendse, Wilma D.J. van de Berg
Published 2010-09-01